For established drugs and vaccines all serious suspected reactions should be reported. These are reactions which are fatal, life-threatening, incapacitating, disabling, or which result in prolonged hospitalisation; they should be reported even if the reaction is well recognised. Newer drugs and vaccines are subject to intense monitoring and they are denoted in the BNFC by the symbol .

Side effects are any undesired effects of the study medication. These effects may include headache, nausea, skin irritation, or other physical problems.

In clinical studies, the most frequent side effect reported was a temporary rash, which was experienced by 5.9% of those studied. So there is a small possibility that your patient will experience some minor skin irritation. Also, if your patient actually receives a defibrillating shock, there is the possibility of minor burns.

Possible histamine-mediated symptoms have been reported with MYCAMINE, including rash, pruritus, facial swelling, and vasodilatation. Injection site reactions, including phlebitis and thrombophlebitis have been reported, at MYCAMINE doses of 50-150 mg/day. These events tended to occur more often in patients receiving MYCAMINE via peripheral intravenous administration.

The most common anticholinergic symptoms were dry mouth, dry eyes, constipation, and difficulty urinating. With OXYTROL, dry mouth occurred in 9.6% of patients in one pivotal study (versus 8.3% with placebo) and 4.1% of patients in the other (versus 1.7% with placebo). No patients discontinued OXYTROL treatment due to dry mouth. Constipation, abnormal vision, and dysuria (painful urination) occurred in 2% to <5% of patients.

No. Stress and B-12 Formulas ™ are necessary and important for proper functioning of bodily systems. They do not adversely interact with any prescription or over-the-counter medication. It is perfectly safe to continue use of any prescription medication with them

Anaphylactoid reactions were not reported in patients receiving Celebrex™ in clinical trials. However, as with NSAIDs in general, anaphylactoid reactions may occur in patients without known prior exposure to Celebrex™. Celebrex™ should not be given to patients with the aspirin triad.

In clinical studies, side effects with plant stanol esters were comparable to placebo. Plant stanol esters have an excellent safety profile. This safety record is further supported by ten years of experience with plant stanol esters consumed as BENECOL? Spread.

Mild local reactions occur in 30% of recipients and consist of slight tenderness and redness at the injection site. Severe local reactions are infrequent and consist of extensive swelling of the forearm in addition to the local reaction. Systemic reactions occur in fewer than 0.2% of recipients.

When vaccines containing thimerosal have been administered in the recommended doses, allergic type reactions (hives, shock) have been noted on rare occasions. No other harmful effects have been reported. No. Infants and children who have received thimerosal-containing vaccines do not need to have blood, urine or hair tested for mercury. The body eliminates a mercury dose completely within 120 days - it doesn't stay in your child's body.

No! You are in complete control, and as long as you follow what you've learned during the session, the only result will be that you are a proud, happy nonsmoker!

Please read the Keflex Prescribing Information or contact MiddleBrook Customer Service at 877-363-8080. KEFLEX is indicated for the treatment of respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections in adults and children six months and older. KEFLEX is contraindicated in patients with known allergy to the cephalosporin group of antibiotics.

In clinical studies, pain (≤4.0%) was the only reported injection site reaction occurring in ≥1% of patients. [1,2]

Because routine vaccination against smallpox was discontinued in 1971 for civilians and in 1990 for military personnel, most young adults and children have not been exposed to the smallpox vaccine. Subsequently, healthcare providers have limited experience administering the smallpox vaccine and monitoring for potential adverse reactions, particularly in the adult population.

It is possible, but unlikely that BOTOX® will produce a mild allergic reaction, which will result in the treatment producing a lesser response. Restylane® or Juvederm™ is non-animal based, which virtually eliminates the possibility of allergic reaction.